TCb vs EC-T in High Risk ER+/HER2- Breast Cancer

Clinical trial NCT05901428 · RECRUITING

Trial details

NCT number: NCT05901428
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Receptor Positive HER-2 Negative Breast Cancer

Start date: 2023-06-01
Primary completion: 2026-06-01
Enrollment: 1736

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.